Home NDC 63323-347-01 NDC 63323-347-01 - Ceftriaxone This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
Product NDC 63323-347
Requested NDC 63323-347-01
Package NDCs from labels 63323-347-01, 63323-347-20
Manufacturer Fresenius Kabi USA, LLC | ACS Dobfar SPA
Effective date 2023-09-30
Current FDA listing Not matched in FDA.report NDC product tables DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 63323-347-01 Ceftriaxone 1 in 1 VIAL INJECTION, POWDER, FOR SOLUTION 1 6 63323-347-20 Ceftriaxone 10 in 1 CARTON INJECTION, POWDER, FOR SOLUTION 10 6
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 63323-347 CEFTRIAXONE INJECTION, POWDER, FOR SOLUTION [FRESENIUS KABI USA, LLC] 6 Legacy NDC, 2 package rows 20231021_7ea1db43-40fa-417b-8911-ae98092070a0.zip
DailyMed Socrata Ingredients# openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 2 of 2 · 34 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Ceftriaxone Sodium CEFTRIAXONE SODIUM A-S Medication Solutions 1aa0a4ee-1b39-4c3d-a7a3-33dded6fe28c 2024-01-31 Warnings, Adverse reactions Exact identifier unii: 023Z5BR09K Ceftriaxone Sodium CEFTRIAXONE SODIUM A-S Medication Solutions ff8e830a-c288-46fb-9e19-ec2017943c07 2024-01-31 Warnings, Adverse reactions Exact identifier unii: 023Z5BR09K ceftriaxone CEFTRIAXONE Sagent Pharmaceuticals 5cf93bc5-9e4c-4734-bc02-c7d0ac071022 2023-11-08 Warnings, Adverse reactions Exact identifier application number: ANDA065329 rxcui: 1665046 rxcui: 1665005 rxcui: 1665021 unii: 023Z5BR09K Ceftriaxone CEFTRIAXONE Fresenius Kabi USA, LLC 7ea1db43-40fa-417b-8911-ae98092070a0 2023-09-30 Warnings, Adverse reactions Exact identifier application number: ANDA065329 ndc (package): 63323-346-10 ndc (package): 63323-345-10 ndc (package): 63323-347-20 ndc (package): 63323-347-01 ndc (package): 63323-346-01 ndc (product): 63323-345 ndc (product): 63323-346 ndc (product): 63323-347 ndc11 (package): 63323034701 rxcui: 1665046 rxcui: 1665005 rxcui: 1665021 spl id: 27777645-c5ae-4c89-abaf-ddb62dc7b859 spl set id: 7ea1db43-40fa-417b-8911-ae98092070a0 unii: 023Z5BR09K Ceftriaxone Sodium CEFTRIAXONE SODIUM Asclemed USA, Inc. f01cf0e5-caaf-4759-ba21-50f3aceff523 2023-09-02 Warnings, Adverse reactions Exact identifier rxcui: 1665005 unii: 023Z5BR09K Ceftriaxone Sodium CEFTRIAXONE SODIUM Apotex Corp. 5116231f-82d1-44be-b08e-560c9a50e5c5 2023-08-31 Warnings, Adverse reactions Exact identifier rxcui: 1665046 rxcui: 1665005 rxcui: 1665021 unii: 023Z5BR09K Ceftriaxone Sodium CEFTRIAXONE SODIUM Apotex Corp. ac03a72c-0e35-40f9-b7fc-081badb5f19c 2023-01-28 Warnings, Adverse reactions Exact identifier unii: 023Z5BR09K Ceftriaxone CEFTRIAXONE SODIUM Samson Medical Technologies, LLC 5cd2d96f-83e5-4326-ae87-d0ede4ba493a 2023-01-15 Warnings, Adverse reactions Exact identifier unii: 023Z5BR09K Ceftriaxone CEFTRIAXONE Proficient Rx LP fcf401df-bcdc-4773-a63b-9741c0f74b3d 2022-11-01 Warnings, Adverse reactions Exact identifier application number: ANDA065329 rxcui: 1665046 unii: 023Z5BR09K Ceftriaxone Sodium CEFTRIAXONE SODIUM Proficient Rx LP a25ab5ea-c46d-4562-8f7e-0ccffc2ab069 2022-10-01 Warnings, Adverse reactions Exact identifier rxcui: 1665046 unii: 023Z5BR09K Ceftriaxone Sodium CEFTRIAXONE SODIUM Proficient Rx LP 42ba7a9d-7d2b-4eac-af59-897151a8c924 2022-05-02 Warnings, Adverse reactions Exact identifier rxcui: 1665021 unii: 023Z5BR09K Ceftriaxone Sodium CEFTRIAXONE SODIUM Hospira, Inc 9d1f630b-e759-4395-9d01-ddc90e4fea75 2022-03-09 Warnings, Adverse reactions Exact identifier rxcui: 1665046 rxcui: 1665021 unii: 023Z5BR09K CEFTRIAXONE AND DEXTROSE CEFTRIAXONE B. Braun Medical Inc. 67153914-16bc-490d-82d7-638061618467 2022-01-13 Warnings, Adverse reactions Exact identifier rxcui: 1665046 rxcui: 1665021 unii: 023Z5BR09K Ceftriaxone CEFTRIAXONE Hikma Pharmaceuticals USA Inc. 1f8776bd-4f5b-427a-849a-6b8338f7997d 2019-04-24 Warnings, Adverse reactions Exact identifier unii: 023Z5BR09K
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.